BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2558454)

  • 1. Association of steroid therapy with vaccine-associated rashes in children with acute lymphocytic leukaemia who received Oka/Merck varicella vaccine. NIAID Varicella Vaccine Collaborative Study Group.
    Lydick E; Kuter BJ; Zajac BA; Guess HA
    Vaccine; 1989 Dec; 7(6):549-53. PubMed ID: 2558454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Varicella vaccine in children with acute lymphoblastic leukemia and non-Hodgkin lymphoma.
    Yeung CY; Liang DC
    Pediatr Hematol Oncol; 1992; 9(1):29-34. PubMed ID: 1313688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of tolerance and effectiveness of a varicella vaccine in leukemic children.
    Bancillon A; Leblanc T; Baruchel A; Schaison G; Leverger G; Mallarmey D; Teuliere L
    Nouv Rev Fr Hematol (1978); 1991; 33(6):555-6. PubMed ID: 1667953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group.
    Hardy I; Gershon AA; Steinberg SP; LaRussa P
    N Engl J Med; 1991 Nov; 325(22):1545-50. PubMed ID: 1658650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and immunogenicity of one vs. two injections of Oka/Merck varicella vaccine in healthy children.
    Ngai AL; Staehle BO; Kuter BJ; Cyanovich NM; Cho I; Matthews H; Keller P; Arvin AM; Watson B; White CJ
    Pediatr Infect Dis J; 1996 Jan; 15(1):49-54. PubMed ID: 8684876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oka/Merck varicella vaccine in healthy children: final report of a 2-year efficacy study and 7-year follow-up studies.
    Kuter BJ; Weibel RE; Guess HA; Matthews H; Morton DH; Neff BJ; Provost PJ; Watson BA; Starr SE; Plotkin SA
    Vaccine; 1991 Sep; 9(9):643-7. PubMed ID: 1659052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Live attenuated varicella virus vaccine. Efficacy trial in healthy children.
    Weibel RE; Neff BJ; Kuter BJ; Guess HA; Rothenberger CA; Fitzgerald AJ; Connor KA; McLean AA; Hilleman MR; Buynak EB
    N Engl J Med; 1984 May; 310(22):1409-15. PubMed ID: 6325909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience with Oka live varicella vaccine in Japan.
    Takahashi M; Kamiya H; Baba K; Asano Y; Ozaki T; Horiuchi K
    Postgrad Med J; 1985; 61 Suppl 4():61-7. PubMed ID: 3014479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicentre trial of live attenuated varicella vaccine in children with leukaemia in remission.
    Gershon AA; Steinberg S; Gelb L; Galasso G; Borkowsky W; LaRussa P; Ferrara A
    Postgrad Med J; 1985; 61 Suppl 4():73-8. PubMed ID: 3014482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Live varicella vaccine in severely immunodepressed children.
    Ninane J; Latinne D; Heremans-Bracke MT; De Bruyere M; Cornu G
    Postgrad Med J; 1985; 61 Suppl 4():97-102. PubMed ID: 3014486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active immunization against varicella of children with acute leukaemia or other malignancies on maintenance chemotherapy.
    Haas RJ; Belohradsky B; Dickerhoff R; Eichinger K; Eife R; Holtmann H; Goetz O; Graubner U; Peller P
    Postgrad Med J; 1985; 61 Suppl 4():69-72. PubMed ID: 3014480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization of children with acute lymphoblastic leukemia with live attenuated varicella vaccine without complete suspension of chemotherapy.
    Arbeter AM; Granowetter L; Starr SE; Lange B; Wimmer R; Plotkin SA
    Pediatrics; 1990 Mar; 85(3):338-44. PubMed ID: 2304787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The safety profile of varicella vaccine: a 10-year review.
    Galea SA; Sweet A; Beninger P; Steinberg SP; Larussa PS; Gershon AA; Sharrar RG
    J Infect Dis; 2008 Mar; 197 Suppl 2():S165-9. PubMed ID: 18419392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical application of a live varicella vaccine (Oka strain) in a hospital.
    Naganuma Y; Osawa S; Takahashi R
    Biken J; 1984 Sep; 27(2-3):59-61. PubMed ID: 6100059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination of children with malignant disease against varicella.
    Slørdahl SH; Wiger D; Strømøy T; Degre M; Thørsby E; Lie SO
    Postgrad Med J; 1985; 61 Suppl 4():85-92. PubMed ID: 3014484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Live attenuated varicella vaccine in healthy 12- to 24-month-old children.
    Johnson CE; Shurin PA; Fattlar D; Rome LP; Kumar ML
    Pediatrics; 1988 Apr; 81(4):512-8. PubMed ID: 2832819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Vaccination of chickenpox in children with acute lymphoblastic leukaemia].
    Navajas A; Astigarraga I; Fernández-Teijeiro A; Aga M; Redondo ML; Roig A; Corral J
    Enferm Infecc Microbiol Clin; 1999 Apr; 17(4):162-5. PubMed ID: 10365508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Varicella vaccination].
    Heidl M; Scholz H
    Padiatr Grenzgeb; 1990; 29(1):31-6. PubMed ID: 2160635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term protective immunity of recipients of the OKA strain of live varicella vaccine.
    Asano Y; Nagai T; Miyata T; Yazaki T; Ito S; Yamanishi K; Takahashi M
    Pediatrics; 1985 Apr; 75(4):667-71. PubMed ID: 2984636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Live attenuated varicella vaccine use in immunocompromised children and adults.
    Gershon AA; Steinberg SP; Gelb L
    Pediatrics; 1986 Oct; 78(4 Pt 2):757-62. PubMed ID: 3020495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.